| Patent | Date |
|---|
Development Of Dengue Virus Vaccine Components
App 20220251521 - Whitehead; Stephen S. ; et al. | 2022-08-11 |
Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus
Grant 11,400,150 - Pletnev , et al. August 2, 2 | 2022-08-02 |
Development of dengue virus vaccine components
Grant 11,332,722 - Whitehead , et al. May 17, 2 | 2022-05-17 |
Attenuated mutant dengue viruses comprising a mutation in the NS5 non-structural protein
Grant 11,318,196 - Whitehead , et al. May 3, 2 | 2022-05-03 |
Construction Of West Nile Virus And Dengue Virus Chimeras For Use In A Live Virus Vaccine To Prevent Disease Caused By West Nile Virus
App 20210069317 - Pletnev; Alexander G. ; et al. | 2021-03-11 |
Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus
Grant 10,869,920 - Pletnev , et al. December 22, 2 | 2020-12-22 |
Dengue Tetravalent Vaccine Containing A Common 30 Nucleotide Deletion In The 3'-utr Of Dengue Types 1,2,3, And 4, Or Antigenic Chimeric Dengue Viruses 1,2,3, And 4
App 20200392469 - Whitehead; Stephen S. ; et al. | 2020-12-17 |
Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3'-utr of dengue types 1, 2, 3, and 4, or antigenic chimeric dengue viruses 1, 2, 3, and 4
Grant 10,837,003 - Whitehead , et al. November 17, 2 | 2020-11-17 |
Development Of Dengue Virus Vaccine Components
App 20200318083 - Whitehead; Stephen S. ; et al. | 2020-10-08 |
Development of dengue virus vaccine components
Grant 10,724,007 - Whitehead , et al. | 2020-07-28 |
Live Attenuated Virus Vaccines For La Crosse Virus And Other Bunyaviridae
App 20200147202 - Whitehead; Stephen S. ; et al. | 2020-05-14 |
Development Of Mutations Useful For Attenuating Dengue Viruses And Chimeric Dengue Viruses
App 20200085939 - Whitehead; Stephen S. ; et al. | 2020-03-19 |
Live attenuated virus vaccines for La Crosse virus and other bunyaviridae
Grant 10,561,724 - Whitehead , et al. Feb | 2020-02-18 |
Construction Of West Nile Virus And Dengue Virus Chimeras For Use In A Live Virus Vaccine To Prevent Disease Caused By West Nile
App 20200030435 - Pletnev; Alexander G. ; et al. | 2020-01-30 |
Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses
Grant 10,500,264 - Whitehead , et al. Dec | 2019-12-10 |
Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus
Grant 10,456,461 - Pletnev , et al. Oc | 2019-10-29 |
Live Attenuated Zika Virus Vaccine
App 20190194260 - Whitehead; Stephen S. ; et al. | 2019-06-27 |
Development Of Dengue Virus Vaccine Components
App 20190119654 - Whitehead; Stephen S. ; et al. | 2019-04-25 |
Live Attenuated Virus Vaccines For La Crosse Virus And Other Bunyaviridae
App 20190117762 - Whitehead; Stephen S. ; et al. | 2019-04-25 |
Live attenuated virus vaccines for la crosse virus and other bunyaviridae
Grant 10,206,995 - Whitehead , et al. Feb | 2019-02-19 |
Construction Of West Nile Virus And Dengue Virus Chimeras For Use In A Live Virus Vaccine To Prevent Disease Caused By West Nile Virus
App 20180369358 - Pletnev; Alexander G. ; et al. | 2018-12-27 |
Development of dengue virus vaccine components
Grant 10,160,957 - Whitehead , et al. Dec | 2018-12-25 |
Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus
Grant 10,058,602 - Pletnev , et al. August 28, 2 | 2018-08-28 |
Development Of Dengue Virus Vaccine Components
App 20180171308 - Whitehead; Stephen S. ; et al. | 2018-06-21 |
Live Attenuated Virus Vaccines For La Crosse Virus And Other Bunyaviridae
App 20180104326 - Whitehead; Stephen S. ; et al. | 2018-04-19 |
Live attenuated virus vaccines for la crosse virus and other bunyaviridae
Grant 9,884,104 - Whitehead , et al. February 6, 2 | 2018-02-06 |
Dengue Tetravalent Vaccine Containing A Common 30 Nucleotide Deletion In The 3'-utr Of Dengue Types 1, 2, 3, And 4, Or Antigenic Chimeric Dengue Viruses 1, 2, 3, And 4
App 20180010099 - Whitehead; Stephen S. ; et al. | 2018-01-11 |
Development Of Mutations Useful For Attenuating Dengue Viruses And Chimeric Dengue Viruses
App 20180008693 - Whitehead; Stephen S. ; et al. | 2018-01-11 |
Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3'-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4
Grant RE46,641 - Whitehead , et al. December 19, 2 | 2017-12-19 |
Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3'-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4
Grant RE46,631 - Whitehead , et al. December 12, 2 | 2017-12-12 |
Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3'-UTR of dengue types 1, 2, 3, and 4, or antigenic chimeric dengue viruses 1, 2, 3, and 4
Grant 9,783,787 - Whitehead , et al. October 10, 2 | 2017-10-10 |
Attenuated mutant dengue viruses comprising a mutation in the NS4B non-structural protein
Grant 9,707,287 - Whitehead , et al. July 18, 2 | 2017-07-18 |
Live Attenuated Virus Vaccines For La Crosse Virus And Other Bunyaviridae
App 20160367657 - Whitehead; Stephen S. ; et al. | 2016-12-22 |
Development of dengue virus vaccine components
Grant RE46,042 - Whitehead , et al. June 28, 2 | 2016-06-28 |
Live attenuated virus vaccines for La Crosse virus and other Bunyaviridae
Grant 9,255,252 - Whitehead , et al. February 9, 2 | 2016-02-09 |
Development of dengue virus vaccine components
Grant 9,090,873 - Whitehead , et al. July 28, 2 | 2015-07-28 |
Development Of Mutations Useful For Attenuating Dengue Viruses And Chimeric Dengue Viruses
App 20150064214 - Whitehead; Stephen S. ; et al. | 2015-03-05 |
Construction Of West Nile Virus And Dengue Virus Chimeras For Use In A Live Virus Vaccine To Prevent Disease Caused By West Nile Virus
App 20140294892 - Pletnev; Alexander G. ; et al. | 2014-10-02 |
Recombinant attenuated dengue viruses comprising a deletion in the 3' untranslated region and additional attenuating mutations induced by chemical mutagenesis
Grant RE45,123 - Whitehead , et al. September 9, 2 | 2014-09-09 |
Attenuated dengue virus comprising mutations in the NS3 gene
Grant RE45,053 - Whitehead , et al. July 29, 2 | 2014-07-29 |
Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus
Grant 8,778,671 - Pletnev , et al. July 15, 2 | 2014-07-15 |
Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses
Grant RE45,016 - Whitehead , et al. July 15, 2 | 2014-07-15 |
Live Attenuated Virus Vaccines For La Crosse Virus And Other Bunyaviridae
App 20140023679 - Whitehead; Stephen S. ; et al. | 2014-01-23 |
Recombinant attenuated dengue viruses comprising mutations in NS5 and the 3' untranslated region
Grant 8,632,782 - Whitehead , et al. January 21, 2 | 2014-01-21 |
Development Of Dengue Virus Vaccine Components
App 20130089567 - Whitehead; Stephen S. ; et al. | 2013-04-11 |
Dengue Tetravalent Vaccine Containing A Common 30 Nucleotide Deletion In The 3'-utr Of Dengue Types 1, 2, 3, And 4, Or Antigenic Chimeric Dengue Viruses 1, 2, 3, And 4
App 20130011433 - Whitehead; Stephen S. ; et al. | 2013-01-10 |
Development of dengue virus vaccine components
Grant 8,337,860 - Whitehead , et al. December 25, 2 | 2012-12-25 |
Live attenuated virus vaccines for La Crosse virus and other Bunyaviridae
Grant 8,298,541 - Whitehead , et al. October 30, 2 | 2012-10-30 |
Development Of Mutations Useful For Attenuating Dengue Viruses And Chimeric Dengue Viruses
App 20120114694 - Whitehead; Stephen S. ; et al. | 2012-05-10 |
Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3'-UTR of dengue types 1, 2, 3, and 4 or antigenic chimeric dengue viruses 1, 2, 3, and 4
Grant 8,075,903 - Whitehead , et al. December 13, 2 | 2011-12-13 |
Recombinant attenuated dengue viruses comprising a deletion in the 3' untranslated region and additional attenuating mutations induced by chemical mutagenesis
Grant 8,039,003 - Whitehead , et al. October 18, 2 | 2011-10-18 |
Live Attenuated Virus Vaccines For La Crosse Virus And Other Bunyaviridae
App 20110200630 - Whitehead; Stephen S. ; et al. | 2011-08-18 |
Chimeric Sle/dengue Type 4 Antigenic Viruses
App 20100316670 - Blaney; Joseph E. ; et al. | 2010-12-16 |
Attenuated chimeric respiratory syncytial virus
Grant 7,846,455 - Collins , et al. December 7, 2 | 2010-12-07 |
Production of attenuated, human-bovine chimeric respiratory syncytial virus vaccines
Grant 7,842,798 - Buchholz , et al. November 30, 2 | 2010-11-30 |
Production of attenuated, human-bovine chimeric respiratory syncytial virus vaccines
Grant 7,829,102 - Buchholz , et al. November 9, 2 | 2010-11-09 |
Production of attenuated, human-bovine chimeric respiratory syncytial viruses for use in immunogenic compositions
Grant 7,820,182 - Buchholz , et al. October 26, 2 | 2010-10-26 |
Respiratory syncytial virus vaccines expressing protective antigens from promotor-proximal genes
Grant 7,744,902 - Krempl , et al. June 29, 2 | 2010-06-29 |
Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences
Grant 7,709,007 - Murphy , et al. May 4, 2 | 2010-05-04 |
Development Of Dengue Virus Vaccine Components
App 20100104598 - Whitehead; Stephen S. ; et al. | 2010-04-29 |
Respiratory syncytial virus vaccines expressing protective antigens from promoter-proximal genes
Grant 7,662,397 - Krempl , et al. February 16, 2 | 2010-02-16 |
Development Of Mutations Useful For Attenuating Dengue Viruses And Chimeric Dengue Viruses
App 20090263424 - Whitehead; Stephen S. ; et al. | 2009-10-22 |
Dengue Tetravalent Vaccine Containing A Common 30 Nucleotide Deletion In The 3' -utr Of Dengue Types 1, 2, 3, And 4 Or Antigenic Chimeric Dengue Viruses 1, 2, 3, And 4
App 20090258036 - Whitehead; Stephen S. ; et al. | 2009-10-15 |
Attenuated dengue virus comprising mutations in the NS3 gene
Grant 7,560,118 - Whitehead , et al. July 14, 2 | 2009-07-14 |
Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3'-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4
Grant 7,517,531 - Whitehead , et al. April 14, 2 | 2009-04-14 |
Polynucleotides encoding recombinant respiratory syncytial viruses expressing immune modulatory molecules
Grant 7,465,794 - Collins , et al. December 16, 2 | 2008-12-16 |
Production of attenuated, human-bovine chimeric respiratory syncytial virus vaccines
App 20070184069 - Buchholz; Ursula ; et al. | 2007-08-09 |
Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses
Grant 7,226,602 - Whitehead , et al. June 5, 2 | 2007-06-05 |
Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses
App 20070092534 - Whitehead; Stephen S. ; et al. | 2007-04-26 |
Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3'-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4
App 20070009552 - Whitehead; Stephen S. ; et al. | 2007-01-11 |
Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences
App 20060159703 - Murphy; Brian R. ; et al. | 2006-07-20 |
Production of attenuated, human-bovine chimeric respiratory syncytial virus vaccines
App 20060057158 - Buchholz; Ursula ; et al. | 2006-03-16 |
Respiratory syncytial virus vaccines expressing protective antigens from promotor-proximal genes
App 20060024797 - Krempl; Christine D. ; et al. | 2006-02-02 |
Respiratory syncytial virus vaccines expressing protective antigens from promotor-proximal genes
App 20060018927 - Krempl; Christine D. ; et al. | 2006-01-26 |
Production of recombinant respiratory syncytial viruses expressing immune modulatory molecules
App 20050220767 - Collins, Peter L. ; et al. | 2005-10-06 |
Respiratory syncytial virus vaccines expressing protective antigens from promoter-proximal genes
Grant 6,923,971 - Krempl , et al. August 2, 2 | 2005-08-02 |
Production of attenuated, human-bovine chimeric respiratory syncytial viruses for use in immunogenic compositions
App 20050158338 - Buchholz, Ursula ; et al. | 2005-07-21 |
Production of recombinant respiratory syncytial viruses expressing immune modulatory molecules
App 20050147622 - Collins, Peter L. ; et al. | 2005-07-07 |
Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus
App 20050100886 - Pletnev, Alexander G. ; et al. | 2005-05-12 |
Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleotide sequences
App 20050100557 - Collins, Peter L. ; et al. | 2005-05-12 |
Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses
App 20050010043 - Whitehead, Stephen S. ; et al. | 2005-01-13 |
Respiratory syncytial virus vaccines expressing protective antigens from promoter-proximal genes
App 20040258714 - Krempl, Christine D. ; et al. | 2004-12-23 |
Production of recombinant respiratory syncytial viruses expressing immune modulatory molecules
Grant 6,699,476 - Collins , et al. March 2, 2 | 2004-03-02 |
Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleotide sequences
Grant 6,689,367 - Collins , et al. February 10, 2 | 2004-02-10 |
Respiratory syncytial virus vaccines expressing protective antigens from promotor- proximal genes
App 20040005542 - Krempl, Christine D ; et al. | 2004-01-08 |
Respiratory syncytial virus vaccines expressing protective antigens from promoter-proximal genes
App 20020146433 - Krempl, Christine D. ; et al. | 2002-10-10 |
Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences
Grant 5,993,824 - Murphy , et al. November 30, 1 | 1999-11-30 |
| 